At Sensei Biotherapeutics, our goal is to understand and selectively interact with the tumor microenvironment in order to tilt the immune system against cancer. The Sensei team brings together leaders with deep expertise in our core disciplines, along with a highly accomplished team of life science business leaders. Collectively our team members have driven dozens of programs into clinical studies and played key roles in developing some of the world’s leading immuno-oncology drugs.

Leadership Team


John K. Celebi, MBA

President & Chief Executive Officer


Erin Colgan

Chief Financial Officer


Patrick Gallagher, MBA, MPH

Chief Business Officer

Edward for web Aug 2022

Edward van der Horst, Ph.D.

Chief Scientific Officer

Chris Gerry 1 17 23

Christopher Gerry, J.D.

Vice President, General Counsel



Robert Pierce, M.D.

Science Fellow

Board of Directors

William Ringo, MBA

Board Chair

Samuel Broder, M.D.

John K. Celebi, MBA

Jessie English, Ph.D.

Bob Holmen, J.D.

Kristian Humer, MBA

James Peyer, Ph.D.

Tom Ricks, MBA

Deneen Vojta, M.D.

Immuno-Oncology Advisory Board

Alain Algazi, M.D.

Stephen Dewhurst, Ph.D.

Maura Gillison, M.D., Ph.D.

Sara Pai, M.D., Ph.D.

Robert Schreiber, Ph.D.

Daniel H. Sterman, M.D.

Richard Ulevitch, Ph.D.

HQ: 451 D St, Unit 710 , Boston, MA 02210

MD: 1405 Research Blvd, Suite 125,
Rockville, MD 20850